News About: Goverment
Government Selects 19 Strategic Investment Areas to Cope with Aging Society
Reflective of a rapid growth of aging population in the domestic society, the government has selected 19 strategic investment areas from 8 industry sectors to address the preparatory measures toward the nation's overa...
Healthcare Regulatory Reforms Made by MOHW
A number of healthcare related regulatory reforms has been suggested forth by the Ministry of Health and Welfare (MOHW) at the Cabinet meeting held last week, addressing the preparatory measures needed for both short ...
KFDA Issues Revised Approval Specifications on Neurontin
The Korea Food and Drug Administration has recently issued the revised market approval specifications on Pfizer Korea's Neurontin (active ingredient: gabapentin) products.
Currently, Neurontin is available in the d...
New GMP Guideline for Biopharmaceutical and Biotech-Based Products
The Korea Food and Drug Administration (KFDA) has recently completed a new administrative guideline for GMP (Good Manufacturing Practice) evaluation as specific to the domestic manufacturers of biopharmaceutical produ...
Government and Drug Makers Face with Seven Lawsuits over PPA Incident
The pharmaceutical industry is making a close observation on the on-going litigation process involving last year's ban on the production and sale of cold remedies containing phenylpropanolamine (PPA), which led to sub...
Illegal Sales of OTC Medications by Unauthorized Retail Outlets Exposed
The Korea Food and Drug Administration (KFDA) announced on January 18th that it has found 15 locations in the Seoul metropolitan district that were conducting an illegal sale of certain over-the-counter (OTC) products...
143 Antibiotic Products with Adjusted Market Approval Specifications
The Korea Food and Drug Administration (KFDA) recently announced a uniform adjustment on the market approval specifications of existing 143 antibiotic products, based on the re-evaluation results on their efficacies, ...
305 New Drug Inclusions to Current Insurance Coverage List
Effective February 1st, a total of 305 drugs is to be newly included in the National Health Insurance (NHI) list of pharmaceutical products with their defined coverages under both reimbursable and non-reimbursable cat...
Revised Government Standards Now Allow Public Advertising of OTC Products
The Korea Food and Drug Administration (KFDA) recently announced an official enforcement of its revised regulatory provision governing the public advertising standards for pharmaceutical products, which was proposed l...
Domestic Phase 3 Clinical Trials Total at 122 Items
The Korea Food and Drug Administration (KFDA) recently released the comprehensive list of pharmaceutical products that are currently undergoing the domestic phase 3 clinical trials.
Including new treatment candidat...
